Low serum lymphocyte level is associated with poor exercise capacity and quality of life in chronic obstructive pulmonary disease.

Scientific Reports
Sung Woo MoonKOLD Study Group

Abstract

The purpose of this study was to evaluate the association of serum lymphocyte level with several clinical parameters in COPD. The study population included 451 COPD patients from the Korean Obstructive Lung Disease cohort study. Serum lymphocyte level was measured every year along with various clinical parameters, such as lung function, 6-min walking (6 MW) distance, quality of life using COPD assessment test (CAT) and St. George's Respiratory Questionnaire (SGRQ) scores, exacerbations, and survival. Serum lymphocyte level less than 20% was considered as a low lymphocyte level. Normal lymphocyte and low lymphocyte groups comprised of 409 (90.7%) and 42 (9.3%) patients, respectively. Clustered analysis showed that patients in low lymphocyte group had a lower post-bronchodilator forced expiratory volume in 1 s % predicted (estimated mean =  - 5.70%; P = 0.001), a lower forced vital capacity % predicted (estimated mean =  - 5.63%; P = 0.005), a shorter 6 MW distance (estimated mean =  - 41.31 m; P < 0.001), a higher CAT score (estimated mean = 2.62; P = 0.013), and a higher SGRQ score (estimated mean = 10.10; P < 0.001). Serum lymphocyte level was not associated with frequent acute exacerbations nor mortality. Low serum lymphocyte...Continue Reading

References

May 1, 1990·Journal of Gerontology·L LehtonenA Lehtonen
Jul 1, 1990·The American Review of Respiratory Disease·C E FuenzalidaK M Hambidge
Jul 27, 2000·The New England Journal of Medicine·P J Barnes
Jul 2, 2002·American Journal of Respiratory and Critical Care Medicine·UNKNOWN ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories
Oct 21, 2005·Chest·Gavin C DonaldsonJadwiga A Wedzicha
May 23, 2006·Immunity & Ageing : I & a·Sudhir GuptaSastry Gollapudi
Sep 28, 2007·Current Medicinal Chemistry·Simonetta BaraldoMarina Saetta
Oct 3, 2007·Chest·Robert E WalterEmelia J Benjamin
Jun 1, 2010·Journal of Women's Health·Tomoko Nishida, Hisataka Sakakibara
Dec 24, 2010·The European Respiratory Journal·N A HernandesM A Spruit
Jun 16, 2011·Current Medicinal Chemistry·J NúñezA Llàcer
Dec 14, 2012·F1000 Medicine Reports·Jin Young Oh, Don D Sin
May 23, 2014·Tuberculosis and Respiratory Diseases·Tai Sun ParkUNKNOWN KOLD Study Group
Sep 12, 2014·Respirology : Official Journal of the Asian Pacific Society of Respirology·Masanori YoshikawaHiroshi Kimura
Apr 15, 2015·Respirology : Official Journal of the Asian Pacific Society of Respirology·Ji Ye JungUNKNOWN KOLD Study
Sep 24, 2015·International Journal of Chronic Obstructive Pulmonary Disease·Cüneyt SaltürkSelahattin Oztas
Aug 20, 2016·Journal of Cardiovascular Medicine·Valentina CarubelliMarco Metra
Mar 1, 2017·International Journal of Chronic Obstructive Pulmonary Disease·Wei XiongJin-Ming Liu
Jul 15, 2018·BMC Pulmonary Medicine·Domenico AcanforaMarco Matteo Ciccone
Nov 23, 2018·International Journal of Chronic Obstructive Pulmonary Disease·Yuliana Pascual-GonzálezSalud Santos
Apr 25, 2019·Yonsei Medical Journal·Won Kyung ChoLark Kyun Kim

❮ Previous
Next ❯

Methods Mentioned

BETA
bronchoalveolar lavage

Software Mentioned

SPSS
SAS

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.